after yesterdays agm statement the share price has risen 50% how much upside is left or is this another false dawn?
http://www.alexa.com/data/details/traffic_details/thewellnessshop.co.uk
womans hour link below.
http://www.bbc.co.uk/radio4/womanshour/04/2008_08_mon.shtml

Screenetics contract win

Ultrasis announces that its recently-acquired screening and wellbeing subsidiary, Screenetics UK Limited ("Screenetics"), has won three new contracts with customers spanning the public and private sectors. The value of the contracts is an estimated £2 million per annum. The revenues are partly conditional on performance, but, based on past experience, Screenetics is confident of fulfilling the contract criteria.

Ultrasis acquired Screenetics on the 4th October 2013 as part of its strategy to broaden the range of products and services it provides and to enable it to become a provider of wellbeing, health and social care services.

The contracts relate to the provision of:

· 9,500 flu vaccinations (currently being delivered, one year contract);
· health screenings as part of a salary sacrifice scheme to a large public sector body (commences February 2014 ,three year contract); and
· employee screening to a large UK corporate company (commences spring 2014, initially one year contract).

"This is positive news for both the Screenetics team and for Ultrasis," said John Smith, Ultrasis' Chief Executive. "We are delighted to have secured these significant contracts so soon after the acquisition and believe Screenetics is now well positioned to secure further contract gains. The strength of Screentics in the wellness and screening market is their absolute focus on quality customer service and in delivering the very best experience for the individual using their services".

Kevin Hollick, Screenetics' Managing Director, said: "We have been strengthened by becoming part of the Ultrasis Group and it is encouraging to see these contracts come to fruition, I am confident that 2014 is going to be a significant year of growth for the Screenetics business. We are planning for the volume of health assessments we provide to quadruple in the next 12 months and these contracts put us well on the way to exceeding our expectations".

He added "2014 also sees the introduction of our first mobile health assessment vehicle which will initially be used to deliver a nationwide road show for a large corporate customer to promote wellbeing in the workplace".





Ends

looks like things are on the turn at last for ult

lol .... again ?

Three year Partnership for "Step Success"

Ultrasis is pleased to announce a three year partnership with Boditrax, a leader in cloud-hosted digital health technologies addressing the fitness, health and corporate wellness sectors. Ultrasis has developed an Application Programming Interface (API) for the recently purchased "Step Success" programme which uses the 'Pebble' activity tracking device. BodiTrax will be the first partners of Ultrasis to access and utilise the API and its currently available features. In addition, Boditrax has signed an initial contract with Ultrasis with a value of £67,500.

Results for the year ended 31 July 2013

Ultrasis, the provider of interactive health care services, announces its audited financial results for the year ended 31 July 2013:

· Revenues of £977,000, a decrease from £1,069,000 in 2012 caused by the continued difficult trading conditions in the UK market
· Operating loss before exceptional costs decreased to £1,238,000 (2012: £1,429,000)
· Cash reserves of £734,000 (2012: £1,284,000)
· New strategy implemented to grow the Company, both by acquisition and organic growth
· Acquisition of the wellness provider, Screenetics announced in October 2013
· Unused loan financing facilities of £2,200,000

Ultrasis PLC New Customer for Ultrasis US Joint Venture

Ultrasis Interactive is delighted to announce that its US joint venture, U Squared Interactive, has won a new contract with Starting Point Behavioral Healthcare, a Florida based Behavioural Health Not for Profit Company.

Laureen Pagel, CEO of Starting Point Behavioral Health said "--- our partnership with U(2) Interactive and the introduction of Beating the Blues to our array of evidenced-based practices has been a goal for the past year. The implementation of Beating the Blues will enhance our service delivery model, allow us to serve more clients, and improve outcomes for those suffering from depression, anxiety, and other mental health problems. We are very excited for this opportunity."

John Smith, Chief Executive at Ultrasis said "I am very excited at the opportunity to work with Starting Point and look at how they can integrate Beating the Blues into their community services. Their passion to deliver the very best service to their clients will ensure that we get the outcomes we are looking for and that can use this as a model for demonstrating the return on investment that it is possible to achieve by utilising computer delivered treatments."

U Squared interactive recently launched a white paper in partnership with Open Minds to help Insurers and Providers in the US identify the return on investment ("ROI") of using Beating the Blues within their services.

"From the payer perspective, the ROI numbers for CCBT are impressive," said Monica E. Oss, the chief executive officer of Open Minds and one of the advisors to the model development process. "Depending on the health plan size and the length of time to ROI, the return ranges from twice to ten times the initial investment in CCBT - in just reduced mental health treatment costs alone. And, whether the payer is a health plan, an Accountable Care Organisation, or a medical home, the power of CCBT to improve consumer well-being and reduce unnecessary service utilization is important."

A white paper outlining the model and the model assumptions is available at no charge in the Open Minds library at: www.openminds.com/library/white-papers/usquared-online-cbt-121913.htm

Ends

Ultrasis announce 3year contract for Step Success

New Beating the Blues 2.0 Application Launched in the US.

Ultrasis is pleased to announce that the new application of its Computerised Cognitive Behavioural Therapy (cCBT) treatment program for depression and anxiety, Beating the Blues 2.0 (BTB 2.0) has been launched in the United States and is now available for new and existing customers.

This follows a complete updating by Ultrasis of both the technology platform and the way that the content is delivered. BTB 2.0 has been developed in close partnership with UPMC and the new application will be distributed in the US by U Squared Interactive, our joint venture with UPMC.

U Squared Interactive Board Member Sharon Hicks said "Beating the Blues 2.0 keeps all the underlying science of the original program, but updates the look, feel and usability. This is very important because while we know that the program works and works well, we also know that the user experience is very important and, with the new program, we've made it more fun and easier to use."

The new developments include:

· Availability on wide range of tablets and mobile devices

· Built to latest industry standards (SCORM)

· Improved security features

· Improved user interface

· Shorter sessions

· New graphics and content design

· Customizable content

Ultrasis chief Executive John Smith said "This is a significant milestone for Ultrasis and our efforts to target the US market. We have made some headway with the previous version of the program but the US market demands the very latest in technology. We have a number of potential customers who are waiting for BTB 2.0 to be released and looking to contract with U Squared Interactive in the coming months. We have also begun the process of wide scale marketing and have recently released a 'white paper' that details the potential return on investment of using Beating the Blues to treat depression and anxiety within the US healthcare system in conjunction with Open Minds."

He added "We will also be releasing the new application within the UK in the next 3 months and have a number of potential partnerships in other countries now that we have the capability to create translated versions in a much more cost effective way"



Ends

Looking positive - some broker interest wouldn't go amiss.

It seems they are getting their act together at last!

Acquisition of Occupational Health Business

Ultrasis announces Acquisition of Occupational Health Business.

Ultrasis the provider of healthcare and wellness services is pleased to announce that it has acquired the business and assets of an Occupational Health and Travel Clinic located in Waterloo, London for a nominal consideration. The Clinic, which was previously owned by Abermed Limited, comes with an annual income of £700,000 from contracts with self-pay clients and is currently generating a small profit. The assets transferred to Ultrasis have a nominal value attached to them.

The Clinic, which will now be known as 'Waterloo Health Clinic', provides a range of Occupational Health, Travel Advice and Vaccination Service and Employment Related Medicals.

"In line with our stated strategy, this acquisition presents an ideal opportunity to further increase the range of services that Ultrasis provides and creates a footprint within Occupational Health, a new but complementary market for the company. It also offers us the opportunity to look at new ways to promote our range of products and services directly to consumers through a 'High Street' presence" says Ultrasis Chief Executive John Smith.

He added "Abermed were looking for a suitable healthcare company to take on the management and delivery of the services and have given a four year commitment to maintain contracts at the current levels; this gives us a very solid basis on which to grow the business further and look at synergies with our recently acquired Wellness business, Screenetics. The Board are delighted to welcome the Medical, Nursing, Management and Administrative Staff to the Ultrasis Group."

Excellent candle atm, with volume.

Public Sector contract win and additional funding

Ultrasis the provider of healthcare and wellness services is pleased to announce that it has secured a major three year public sector contract (the "New Contract") through its recently acquired Screenetics business. The detailed terms of the New Contract are deemed confidential due to the nature of the contract but the following material details can be released:

Outline terms of the New Contract:

· The contract term is for a minimum of 3 years
· The Board expects the New Contract to involve the assessment of over 80,000 people over the 3 year period
· There is no minimum contract value although the Board believes the potential value to Ultrasis to be in excess of £8,000,000 over the term of the New Contract
· The Board expect the New Contract to generate income to the Ultrasis group from July 2014
· The services to be provided by Ultrasis under the New Contract will be delivered initially from 10 locations in England
· Subject to certain conditions, the New Contract has the potential for volume to be increased during the term and extended by a further year
· The New Contract requires Ultrasis to deliver its services to a very specific timescale, quality standards and outcomes

Additional Funding

This substantial New Contract also requires additional working capital to fund the establishment of significant infrastructure during the set-up period and to ensure that employees are delivering to an established quality framework. The Company's largest shareholder, Paul Bell, who holds 22.2% of the issued ordinary share capital, has today signed a non-transferable £450,000 convertible debt facility (the "Convertible Debt Facility" or "CDF"), the terms of which are:

· the CDF (to the extent drawn down) together with a premium of 100% of the amount drawn down, will be convertible into Ordinary Shares (either in full or in tranches), at any time at Mr Bell's request at a price per ordinary share in the capital of the Company ("Ordinary Share") equal to 1.03 pence, being the mid-market price of an Ordinary Share on the business day immediately preceding the entering into of the CDF
· the CDF has a 0% coupon
· the CDF is unsecured
· the CDF is for a fixed terms of two years
· any amount drawn down under the CDF which remains unconverted at the end of the term is repayable at a 10% premium
· any conversion of the CDF will be subject to Mr Bell not being able to increase his percentage holding in the Company (on a fully diluted basis) beyond 29.9% if such conversion would trigger a mandatory offer under the provisions of the Takeover Code.

In addition, Mr Bell has agreed that all amounts of interest owing to him (or which become owed to him) under existing other loan facilities he has with the Company will be rolled up into the principal amount of those loans in order to reduce the short term cash working capital requirements of the Company during the periods whilst those loans remain outstanding.


more...

Successful VA "peer supported pilot project"

Ultrasis plc ("Ultrasis" or "the Company")

"Beating the Blues"

Successful VA "peer supported pilot project" and RCT funding approval

Ultrasis plc is pleased to provide details of the published outcomes from the VA pilot project conducted by researchers from the US Veterans Administration ("VA"), C. Beau Nelson, Ph.D., Kristen Abraham, Ph.D., Heather Walters, M.S., and Marcia Valenstein, M.D., M.S and published in the Journal Computers in Human Behavior Number 31 February 2014.

The highlights of the research showed:

· Completion rates for the computer-based Cognitive Behavioural Therapy program were high
· Veteran-peers provided support and helped prompt completion of the Computer-based Cognitive Behavioral Therapy ("cCBT") program
· Significant decreases in depressive symptoms and increases in hope were observed in post ratings
· Marginal decreases in anxiety symptoms were also observed
· The feasibility of a Veteran-peer assisted cCBT program was supported

Interim Results

Ultrasis, the provider of interactive health care services, announces its unaudited financial results for the six months ended 31 January 2014 (the "Interim Results"):

· Revenue of £475,000 (2013: £486,000)
· Loss before tax of £559,000 (2013: £632,000) including costs of approximately £100,000 regarding three completed acquisitions
· Substantial reduction in ongoing overheads
· Cash balances of £190,000 (2013: (restated) £372,000)
· The Group has unused loan facilities of £1,625,000
· Highlights of the period include:
o Completion of three acquisitions: Screenetics, Step Success and Waterloo Health Clinic
o Contract wins which, the Directors believe, have the potential to add over £10 million of income over the next three years which will begin to generate income later this year
o Creating a new joint venture company with the NHS: Ki Group, with a primary objective of creating public sector sales opportunities for Beating the Blues
o Launch of Beating the Blues 2.0 in the US following significant content and technology platform development
· Expecting further growth in the second half of this year as the Group moves towards profitability

John Smith, CEO commented "We are pleased with the substantial progress we have made in the first half and are delighted with our recent acquisitions which are now all integrated into the Group. We look forward to further progress in the second half and beyond."

Mr Smith better be right!!!!Revenue of £475.000 for period 1/7/13-31/12/13 hardly impressive

Contract Win

Contract win for Beating the Blues

Ultrasis is pleased to announce that it has won a contract to provide its on-line depression treatment programme, Beating the Blues ("BTB") in Scotland.

The contract will enable NHS Scotland to use the program in five of its Health Boards over the next three years.

'We are delighted to win this contract which will involve the wide scale deployment of Beating the Blues" said Ultrasis Chief Executive John Smith.

He added "In Scotland BTB has consistently shown its value in helping to increase access to evidence based treatment for depression and anxiety and has become a valuable component of the wider service offering."

Trading Statement

Highlights

· Invoiced sales for the year will be approximately £2 million (2012/13: £0.7 million)
· Staff team increased from 20 to over 50 and continues to grow
· Secured a three year contract through Screenetics to deliver health assessments that has the potential to deliver over £2 million sales per annum
· Secured a three year contract to provide on-line mental health support within 5 of the 14 Health Boards in Scotland
· Continue to invest in the development of several key on-line products and released the 'My Health Coach' app in both apple and android platforms

sales of £2m?
that is truly pathetic

does "staff team" really mean "employees"?
if so, that is mind-blowingly AWFUL

Partnership to launch health screening program

Screenetics partner with BMI Hospitals and Benenden Wellbeing Limited to launch health screening programme.

The Ultrasis Group announces that it has agreed a partnership with BMI Healthcare and Benenden Wellbeing Limited to offer a range of health screening and health care services to members of Benenden and the general population. This will be branded Benenden Health Assessment.

Outline of the partnership:

· Benenden Health Assessment will be delivered in partnership with BMI Healthcare and Screenetics, a subsidiary of Ultrasis.
· The health assessments will be available to c.900,000 members of Benenden Wellbeing Limited's parent, the Benenden Healthcare Society, their families and to the general public.
· They will be available across the UK and delivered from our network of clinics, mobile vehicles and at BMI Healthcare hospitals.
· The screenings are priced from £89 to £499.
· Benenden Wellbeing will be promoting the offer throughout their membership through a marketing campaign using their magazine, social networking and call centre activity.
· BMI Healthcare is the UK's largest independent provider of private healthcare with 62 hospitals and healthcare facilities throughout the country.
· All Benenden Healthcare Society members will be offered the opportunity to complete the newly developed Ultrasis Health Risk Assessment ("HRA") which is available from a wide range of devices including smart phones and tablets. The HRA has been developed specifically to support this partnership and is designed to encourage personal health and wellbeing.